Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis

Vasomotor Rhinitis Clinical Trial

Official title:
Efficacy and Safety of Cossac L Tablet in Vasomotor Rhinitis Patients : A Randomized, Double-blind, Placebo-controlled, Phase 3 Clinical Trial

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate efficacy and safety of Cossac L tablet in the treatment of vasomotor rhinitis

Clinical Trial Description

randomized, double-blind, placebo-controlled, phase 3 ;

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01509209
Study type	Interventional
Source	Hanmi Pharmaceutical Company Limited
Contact
Status	Completed
Phase	Phase 3
Start date	May 2011
Completion date	April 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00979615` - Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis	Phase 4
Completed	`NCT00745849` - Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial	N/A
Recruiting	`NCT05348148` - Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis	N/A
Completed	`NCT00118703` - Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis	Phase 3
Completed	`NCT00682162` - Impact of Acupuncture on Vasomotor Rhinitis	Phase 3
Completed	`NCT00415493` - Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation	N/A
Completed	`NCT00976209` - Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)	Phase 3